Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 347 (9013), 1432-1438
- https://doi.org/10.1016/s0140-6736(96)91681-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Potential Immunological Action of Purine Nucleoside AnaloguesDrugs, 1994
- Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemiaAnnals of Oncology, 1993
- High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.Journal of Clinical Oncology, 1993
- Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia Patients Treated with FludarabineLeukemia & Lymphoma, 1993
- CHOP Versus Chlorambucil + Prednisolone in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1991
- Chlorambucil/Prednisone versus CHOP in Symptomatic Chronic Lymphocytic Leukemias of B-Cell type. A Randomized TrialLeukemia & Lymphoma, 1991
- Treatment of Chronic Lymphocytic Leukemia: A Preliminary Report of Spanish (Pethema) TrialsLeukemia & Lymphoma, 1991
- Role of natural killer cells in the modulation of primary antibody production by purine nucleosides and their analogsCellular Immunology, 1990
- Long-Term Results of CAP Therapy in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1990
- Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working groupAmerican Journal of Hematology, 1988